4.8 Editorial Material

After Theranos

Journal

NATURE BIOTECHNOLOGY
Volume 35, Issue 1, Pages 11-15

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.3761

Keywords

-

Ask authors/readers for more resources

The implosion of blood diagnostics developer Theranos has raised the question: What is feasibly detectible in a drop of blood? Emily Waltz reports.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available